Cubist Systematic Strategies, LLC Athenex, Inc. Transaction History

Cubist Systematic Strategies, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.79 - $1.59 $34,814 - $70,069	-44,069 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.36 - $2.94 $30,111 - $65,094	22,141 Added 100.97%	44,069 $60,000
Q3 2021 Nov 15, 2021	BUY	$2.97 - $4.84 $65,126 - $106,131	21,928 New	21,928 $66,000
Q2 2021 Aug 16, 2021	SELL	$3.71 - $5.13 $184,476 - $255,084	-49,724 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$4.08 - $14.75 $6,846 - $24,750	-1,678 Reduced 3.26%	49,724 $214,000
Q4 2020 Feb 16, 2021	SELL	$11.06 - $14.01 $1.1 Million - $1.39 Million	-99,279 Reduced 65.89%	51,402 $569,000
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $1.28 Million - $1.82 Million	124,925 Added 485.03%	150,681 $1.82 Million
Q2 2020 Aug 14, 2020	SELL	$7.11 - $13.76 $142,455 - $275,695	-20,036 Reduced 43.75%	25,756 $354,000
Q1 2020 May 15, 2020	BUY	$5.71 - $15.85 $118,688 - $329,458	20,786 Added 83.12%	45,792 $354,000
Q4 2019 Feb 14, 2020	SELL	$9.6 - $17.75 $238,617 - $441,194	-24,856 Reduced 49.85%	25,006 $382,000
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $528,169 - $912,135	43,435 Added 675.82%	49,862 $607,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $60,670 - $127,254	6,427 New	6,427 $127,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.